Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the efficacy and safety of
THVD-201(Combination of tolterodine and pilocarpine) in patients with Overactive bladder
during the period of treatment, 12 weeks.
This study also includes an open label extension period of an additional 12 weeks following
the treatment to assess long-term efficacy and safety of THVD-201 in patients with Overactive
bladder.